-
公开(公告)号:US11465969B2
公开(公告)日:2022-10-11
申请号:US17263224
申请日:2019-08-16
Applicant: AMGEN INC. , CYTOKINETICS, INC.
Inventor: Henry Morrison , Sheng Cui , Kyle Quasdorf , Evelyn Yanez , Bin Peter Quan , Ron C. Kelly , Sebastien Caille , Lingyun Xiao , David Pearson , Jaclyn Raeburn , Ailsa Golightly , Bradley Morgan , Matthew Peterson , Alex Eberlin , Alexander Oblezov
IPC: C07D213/75
Abstract: Provided herein are free base crystalline forms, crystalline salts, and an amorphous salts of omecamtiv mecarbil.
-
公开(公告)号:US20200308143A1
公开(公告)日:2020-10-01
申请号:US16607940
申请日:2018-06-29
Applicant: AMGEN INC.
Inventor: Sebastien Caille , Kyle Quasdorf , Philipp Roosen , Xianqing Shi , Andrew Cosbie , Fang Wang , Zufan Wu , Archana Neergunda , Bin Peter Quan , Lianxiu Guan
IPC: C07D401/12 , C07D241/04
Abstract: Provided herein is a synthesis for omecamtiv mecarbil dihydrochloride hydrate and various intermediates. (I)
-
公开(公告)号:US12269811B2
公开(公告)日:2025-04-08
申请号:US18359467
申请日:2023-07-26
Applicant: Amgen Inc.
Inventor: Sebastien Caille , Kyle Quasdorf , Philipp C. Roosen , Xianqing Shi , Andrew Cosbie , Fang Wang , Zufan Wu , Archana Neergunda , Bin Peter Quan , Lianxiu Guan
IPC: C07D295/205 , C07D213/75 , C07D241/04 , C07D401/12
Abstract: Provided herein is a synthesis for omecamtiv mecarbil dihydrochloride hydrate and various intermediates. (1)
-
公开(公告)号:US11926592B2
公开(公告)日:2024-03-12
申请号:US17929645
申请日:2022-09-02
Applicant: Amgen Inc.
Inventor: Henry Morrison , Sheng Cui , Kyle Quasdorf , Evelyn Yanez , Bin Peter Quan , Ron C. Kelly , Sebastien Caille , Lingyun Xiao , David Pearson , Jaclyn Raeburn , Alisa Golightly
IPC: C07D213/75
CPC classification number: C07D213/75 , C07B2200/13
Abstract: Provided herein are free base crystalline forms, crystalline salts, and an amorphous salts of omecamtiv mecarbil.
-
公开(公告)号:US11753394B2
公开(公告)日:2023-09-12
申请号:US17324867
申请日:2021-05-19
Applicant: AMGEN INC.
Inventor: Sebastien Caille , Kyle Quasdorf , Philipp C. Roosen , Xianqing Shi , Andrew Cosbie , Fang Wang , Zufan Wu , Archana Neergunda , Bin Peter Quan , Lianxiu Guan
IPC: C07D401/12 , C07D241/04
CPC classification number: C07D401/12 , C07D241/04
Abstract: Provided herein is a synthesis for omecamtiv mecarbil dihydrochloride hydrate and various intermediates.
-
公开(公告)号:US20210371397A1
公开(公告)日:2021-12-02
申请号:US17324867
申请日:2021-05-19
Applicant: AMGEN INC.
Inventor: Sebastien Caille , Kyle Quasdorf , Philipp C. Roosen , Xianqing Shi , Andrew Cosbie , Fang Wang , Zufan Wu , Archana Neergunda , Bin Peter Quan , Lianxiu Guan
IPC: C07D401/12 , C07D241/04
Abstract: Provided herein is a synthesis for omecamtiv mecarbil dihydrochloride hydrate and various intermediates.
-
公开(公告)号:US20210221771A1
公开(公告)日:2021-07-22
申请号:US17263224
申请日:2019-08-16
Applicant: AMGEN INC. , CYTOKINETICS, INC.
Inventor: Henry Morrison , Sheng Cui , Kyle Quasdorf , Evelyn Yanez , Bin Peter Quan , Ron C. Kelly , Sebastien Caille , Lingyun Xiao , David Pearson , Jaclyn Raeburn , Ailsa Golightly , Bradley Morgan , Matthew Peterson , Alex Eberlin , Alexander Oblezov
IPC: C07D213/75
Abstract: Provided herein are free base crystalline forms, crystalline salts, and an amorphous salts of omecamtiv mecarbil.
-
公开(公告)号:US11040956B2
公开(公告)日:2021-06-22
申请号:US16607940
申请日:2018-06-29
Applicant: AMGEN INC.
Inventor: Sebastien Caille , Kyle Quasdorf , Philipp Roosen , Xianqing Shi , Andrew Cosbie , Fang Wang , Zufan Wu , Archana Neergunda , Bin Peter Quan , Lianxiu Guan
IPC: C07D295/205 , C07D213/75 , C07D401/12 , C07D241/04
Abstract: Provided herein is a synthesis for omecamtiv mecarbil dihydrochloride hydrate and various intermediates. (I)
-
-
-
-
-
-
-